Martin J Duvall - Net Worth and Insider Trading
Martin J Duvall Net Worth
The estimated net worth of Martin J Duvall is at least $2 Million dollars as of 2024-11-13. Martin J Duvall is the EVP, CCO of ARIAD Pharmaceuticals Inc and owns about 93,039 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $2 Million. Martin J Duvall is also the CEO of Tocagen Inc and owns about 907 shares of Tocagen Inc (TOCA) stock worth over $17,142. Details can be seen in Martin J Duvall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin J Duvall has not made any transactions after 2019-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Martin J Duvall
Martin J Duvall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin J Duvall owns 2 companies in total, including Forte Biosciences Inc (FBRX) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Martin J Duvall’s form 4 insider trades.
Insider Ownership Summary of Martin J Duvall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FBRX | Forte Biosciences Inc | 2017-04-12 | director & Chief Executive Officer |
| ARIA | ARIAD Pharmaceuticals Inc | 2016-04-29 | EVP & CCO |
Martin J Duvall Latest Holdings Summary
Martin J Duvall currently owns a total of 2 stocks. Among these stocks, Martin J Duvall owns 93,039 shares of ARIAD Pharmaceuticals Inc (ARIA) as of March 19, 2016, with a value of $2 Million and a weighting of 99.24%. Martin J Duvall also owns 907 shares of Tocagen Inc (TOCA) as of May 28, 2019, with a value of $17,142 and a weighting of 0.76%.
Latest Holdings of Martin J Duvall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-19 | 93,039 | 23.99 | 2,232,006 |
| TOCA | Tocagen Inc | 2019-05-28 | 907 | 18.90 | 17,142 |
Holding Weightings of Martin J Duvall
Martin J Duvall Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin J Duvall has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 4,000 shares on March 19, 2016, which brought Martin J Duvall around $25,880.
According to the SEC Form 4 filings, Martin J Duvall has made a total of 0 transactions in Tocagen Inc (TOCA) over the past 5 years. The most-recent trade in Tocagen Inc is the acquisition of 333 shares on May 28, 2019, which cost Martin J Duvall around $21,700.
Insider Trading History of Martin J Duvall
- 1
Martin J Duvall Trading Performance
GuruFocus tracks the stock performance after each of Martin J Duvall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin J Duvall is -14.94%. GuruFocus also compares Martin J Duvall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin J Duvall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin J Duvall's insider trading performs compared to the benchmark.
Performance of Martin J Duvall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 54.63 | | | | | |
| Relative Return to S&P 500(%) | 49.66 | | | | | |
Martin J Duvall Ownership Network
Ownership Network List of Martin J Duvall
Ownership Network Relation of Martin J Duvall
Martin J Duvall Owned Company Details
What does Forte Biosciences Inc do?
Who are the key executives at Forte Biosciences Inc?
Martin J Duvall is the director & Chief Executive Officer of Forte Biosciences Inc. Other key executives at Forte Biosciences Inc include director & See Remarks Paul A. Wagner , See remarks Hubert C Chen , and Chief Financial Officer Antony A Riley .
Forte Biosciences Inc (FBRX) Insider Trades Summary
Over the past 18 months, Martin J Duvall made no insider transaction in Forte Biosciences Inc (FBRX). Other recent insider transactions involving Forte Biosciences Inc (FBRX) include a net purchase of 118,865 shares made by Paul A. Wagner ,
In summary, during the past 3 months, insiders sold 0 shares of Forte Biosciences Inc (FBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forte Biosciences Inc (FBRX) were sold and 4,755 shares were bought by its insiders, resulting in a net purchase of 4,755 shares.
Forte Biosciences Inc (FBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Forte Biosciences Inc Insider Transactions
Martin J Duvall Mailing Address
Above is the net worth, insider trading, and ownership report for Martin J Duvall. You might contact Martin J Duvall via mailing address: Mgi Pharma, Inc., 5775 West Old Shakopee Road, Suite 100, Bloomington Mn 55437.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
